Robyn Adams
Corporate Officer/Principal chez Washington State Bar Association
Profil
Robyn Adams is a professional who has worked in various legal positions.
Currently, Robyn is a member of the Washington State Bar Association.
Previously, Robyn worked as in-house counsel for ZymoGenetics, Inc., General Counsel for HS Winddown, Inc., and in-house counsel for Epigenomics, Inc. Robyn received an undergraduate degree from the University of Washington and a graduate degree from Seattle University School of Law.
Postes actifs de Robyn Adams
| Sociétés | Poste | Début |
|---|---|---|
Washington State Bar Association
 Washington State Bar Association Miscellaneous Commercial ServicesCommercial Services The Washington State Bar Association operates the state bar association. | Corporate Officer/Principal | - |
Anciens postes connus de Robyn Adams
| Sociétés | Poste | Fin |
|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Epigenomics, Inc.
 Epigenomics, Inc. Miscellaneous Commercial ServicesCommercial Services Epigenomics, Inc. operates as a molecular diagnostics company. It focuses on blood-based detection of cancers using its proprietary DNA methylation technology. The firm develops and commercializes blood-based diagnostic products across multiple cancer indications with high medical need. The company was founded in 1997 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
HS Winddown, Inc.
 HS Winddown, Inc. Medical SpecialtiesHealth Technology HS Winddown, Inc. engages in provision of clean water technology, that provides solutions to the growing issue of water stress. It focuses on providing cleaner, clearer, safer water using its proprietary platforms of N-halamine polymers to purify drinking water, killing bacteria and viruses that may cause diseases. The company was founded on March 18, 1997 and is headquartered in Mukilteo, WA. | Conseiller Juridique Général | - |
Formation de Robyn Adams
| University of Washington | Undergraduate Degree |
| Seattle University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
HS Winddown, Inc.
HS Winddown, Inc. Medical SpecialtiesHealth Technology HS Winddown, Inc. engages in provision of clean water technology, that provides solutions to the growing issue of water stress. It focuses on providing cleaner, clearer, safer water using its proprietary platforms of N-halamine polymers to purify drinking water, killing bacteria and viruses that may cause diseases. The company was founded on March 18, 1997 and is headquartered in Mukilteo, WA. | Health Technology |
Washington State Bar Association
Washington State Bar Association Miscellaneous Commercial ServicesCommercial Services The Washington State Bar Association operates the state bar association. | Commercial Services |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Epigenomics, Inc.
Epigenomics, Inc. Miscellaneous Commercial ServicesCommercial Services Epigenomics, Inc. operates as a molecular diagnostics company. It focuses on blood-based detection of cancers using its proprietary DNA methylation technology. The firm develops and commercializes blood-based diagnostic products across multiple cancer indications with high medical need. The company was founded in 1997 and is headquartered in Seattle, WA. | Commercial Services |
